BENZODIAZEPINE RECEPTOR QUANTIFICATION IN-VIVO IN HUMANS USING [C-11] FLUMAZENIL AND PET - APPLICATION OF THE STEADY-STATE PRINCIPLE

被引:173
|
作者
LASSEN, NA
BARTENSTEIN, PA
LAMMERTSMA, AA
PREVETT, MC
TURTON, DR
LUTHRA, SK
OSMAN, S
BLOOMFIELD, PM
JONES, T
PATSALOS, PN
OCONNELL, MT
DUNCAN, JS
ANDERSEN, JV
机构
[1] NOVO NORDISK AS, DEPT DRUG METAB, DIV CNS, MALOV, DENMARK
[2] HAMMERSMITH HOSP, MRC, CYCLOTRON UNIT, LONDON W12 0HS, ENGLAND
[3] NATL HOSP, DEPT CLIN NEUROL, LONDON WC1N 3BG, ENGLAND
来源
关键词
BENZODIAZEPINE RECEPTORS (IN VIVO; FLUMAZENIL; POSITRON EMISSION TOMOGRAPHY; RO; 15-1788;
D O I
10.1038/jcbfm.1995.17
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Carbon-11-labeled flumazenil combined with positron emission tomography (PET) was used to measure the concentration (B-max) of the benzodiazepine (Bz) receptor in the brain and its equilibrium dissociation constant (K-D) for flumazenil in five normal subjects. The steady-state approach was used injecting the tracer as a bolus of high specific activity. In each subject two studies were carried out. The first study was performed at essentially zero receptor occupancy, the tracer alone study. The second study was performed at a steady-state receptor occupancy of about 50%, achieved by a prolonged constant infusion of nonlabeled (''cold'') flumazenil starting 2 h before the bolus tracer injection and continuing until the end of the scanning period. In this second study the free concentration of unmetabolized flumazenil in plasma water was measured in multiple blood samples. The observed tissue and plasma tracer curves, calibrated in the same units of radioactivity per millimeter, were analyzed in two ways: (a) by the noncompartmental (stochastic) approach making no assumptions regarding number of compartments in the tissue, and (b) by the single-compartment approach assuming rapid exchange (mixing) of tracer between all tissue compartments. The noncompartmental and the compartmental analyses gave essentially the same values for the distribution volume of the tracer, the parameter used for quantitation of the Bz receptor. As the compartmental approach could be applied to a shorter observation period (60 min instead of 120 min) it was preferred. The five subjects had a mean K-D value of 12 nM/L of water and B-max values of the grey matter ranging from 39 +/- 11 in thalamus to 120 +/- 14 nM/L of brain in occipital cortex. Most previous studies have been based on the pseudoequilibrium approach using the brain stem as a receptor-free reference region. This yields practically the same K-D but lower B-max values than the steady-state approach presented here.
引用
收藏
页码:152 / 165
页数:14
相关论文
共 50 条
  • [1] Aging and human brain benzodiazepine receptor: PET and C-11 flumazenil study.
    Ishizu, K
    Akita, Y
    Mukai, T
    Hashikawa, K
    Kitano, H
    Mamede, M
    Saga, T
    Konishi, J
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 16P - 16P
  • [2] QUANTIFICATION OF BENZODIAZEPINE RECEPTORS IN HUMAN BRAIN USING PET, [C-11] FLUMAZENIL, AND A SINGLE-EXPERIMENT PROTOCOL
    DELFORGE, J
    PAPPATA, S
    MILLET, P
    SAMSON, Y
    BENDRIEM, B
    JOBERT, A
    CROUZEL, C
    SYROTA, A
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1995, 15 (02): : 284 - 300
  • [3] MEASUREMENT OF BENZODIAZEPINE RECEPTOR NUMBER AND AFFINITY IN HUMANS USING TRACER KINETIC MODELING, POSITRON EMISSION TOMOGRAPHY, AND [C-11] FLUMAZENIL
    PRICE, JC
    MAYBERG, HS
    DANNALS, RF
    WILSON, AA
    RAVERT, HT
    SADZOT, B
    RATTNER, Z
    KIMBALL, A
    FELDMAN, MA
    FROST, JJ
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1993, 13 (04): : 656 - 667
  • [4] [C-11]-flumazenil PET reveals central benzodiazepine receptor binding abnormalities in partial epilepsy with normal MRI
    Richardson, MP
    Koepp, MJ
    Brooks, DJ
    Duncan, JS
    NEUROLOGY, 1996, 46 (02) : 1027 - 1027
  • [5] IN-VIVO QUANTIFICATION OF PULMONARY BETA-ADRENOCEPTOR DENSITY IN HUMANS WITH (S)-[C-11]CGP-12177 AND PET
    UEKI, J
    RHODES, CG
    HUGHES, JMB
    DESILVA, R
    LEFROY, DC
    IND, PW
    QING, F
    BRADY, F
    LUTHRA, SK
    STEEL, CJ
    WATERS, SL
    LAMMERTSMA, AA
    CAMICI, PG
    JONES, T
    JOURNAL OF APPLIED PHYSIOLOGY, 1993, 75 (02) : 559 - 565
  • [6] NEURORECEPTOR QUANTIFICATION IN-VIVO BY THE STEADY-STATE PRINCIPLE AND [I-123] IOMAZENIL IN RATS
    VIDEBAEK, C
    ANDERSEN, JV
    DALGAARD, L
    FOGED, C
    PAULSON, OB
    LASSEN, AN
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (02) : 117 - 122
  • [7] Design of Infusion Schemes for Neuroreceptor Imaging: Application to [11C] Flumazenil-PET Steady-State Study
    Feng, Ling
    Svarer, Claus
    Madsen, Karine
    Ziebell, Morten
    Dyssegaard, Agnete
    Ettrup, Anders
    Hansen, Hanne Demant
    Lehel, Szabolcs
    Yndgaard, Stig
    Paulson, Olaf Bjarne
    Knudsen, Gitte Moos
    Pinborg, Lars Hageman
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [8] INVESTIGATION OF CENTRAL BENZODIAZEPINE RECEPTORS (BZRS) IN PRIMARY GENERALIZED EPILEPSY (PGE) USING C-11 FLUMAZENIL PET
    PREVETT, MC
    LAMMERTSMA, AA
    BROOKS, DJ
    BARTENSTEIN, PA
    OSMAN, S
    TURTON, D
    OCONNELL, MT
    PATSALOS, PN
    FISH, DR
    DUNCAN, JS
    NEUROLOGY, 1993, 43 (04) : A354 - A354
  • [9] Extensive abnormalities of central benzodiazepine receptors in cortical dysgenesis revealed by [C-11]-flumazenil PET
    Duncan, JS
    Richardson, MP
    Koepp, MJ
    Fish, DR
    Brooks, DJ
    NEUROLOGY, 1996, 46 (02) : 1028 - 1028
  • [10] Reference tissue compartment model for non-invasive quantification of benzodiazepine receptor binding using 11C-Flumazenil and PET.
    Katoh, C
    Tsukamoto, M
    Kaji, T
    Shiga, T
    Nakada, K
    Tsukamoto, E
    Kuge, Y
    Tamaki, N
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 55P - 55P